United States - English - NLM (National Library of Medicine)

virbac ah, inc - itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4) - do not administer to cats with hypersensitivity to itraconazole. not for use in humans. keep this and all medications out of reach of children. wash hands and exposed skin after use. in case of accidental contact with eyes, rinse thoroughly with water. in case of pain or irritation, seek medical advice. in case of accidental ingestion, rinse mouth with water and seek medical advice. special precautions for person administering the veterinary product to the animal: microsporum canis dermatophytosis is a zoonotic disease (a disease that can be transmitted from animals to humans); therefore consult a physician if a suspected lesion occurs on a human. wear protective gloves when handling the animal during treatment or when cleaning the syringe. wash hands and exposed skin after handling the animal. itrafungol (itraconazole oral solution) has not been shown to be sporicidal; therefore in order to reduce zoonotic potential, environmental contamination, and to decrease course of the disease, topical and environment

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - itraconazole, quantity: 100 mg - capsule, hard - excipient ingredients: macrogol 20000; titanium dioxide; gelatin; hypromellose; indigo carmine; erythrosine; maize starch; sucrose - sporanox is indicated for use in adults for the treatment of: superficial dermatomycoses not responding to topical treatment. fungal keratitis which has failed to respond to topical treatment or where the disease is either progressing rapidly or is immediately sight threatening. pityriasis versicolor not responding to any other treatment. vulvovaginal candidiasis not responding to topical treatment. oral candidiasis in immunocompromised patients. onychomycosis caused by dermatophytes. systemic mycoses: -systemic aspergillosis, histoplasmosis, sporotrichosis. -treatment and maintenance therapy in aids patients with disseminated or chronic pulmonary histoplasmosis infection. -treatment of oropharyngeal and/or oesophageal candidiasis when fist line systemic antifungal therapy is inappropriate or has proven ineffective. -treatment of non-invasive candidiasis in non-neutropenic patients when first-line systemic antifungal therapy is inappropriate or has proven ineffective. this may be due to underlying pathology,

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - itraconazole - hard capsule - itraconazole 100 mg - antimycotics for systemic use

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kaken pharmaceutical co., ltd. - itraconazole - white to grayish tablet, diameter: 8.5mm, thickness: 3.7mm

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pahang pharmacy sdn. bhd. - itraconazole -

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - itraconazole - capsule, hard - 100 milligram(s) - triazole derivatives; itraconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - itraconazole - concentrate and solvent for solution for infusion - 10 milligram(s)/millilitre - triazole derivatives; itraconazole

Singapore - English - HSA (Health Sciences Authority)

goldplus universal pte ltd - itraconazole - solution - itraconazole 10 mg/ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

age d`or sdn. bhd. - itraconazole -

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - itraconazole - oral solution - 10 milligram(s)/millilitre - triazole derivatives; itraconazole